卡铂通过激活p53/miR-145轴在头颈癌中的作用机制
该实验室研究探讨卡铂对头颈鳞癌细胞中miR-145及其直接靶点表达的影响。研究发现卡铂剂量依赖性诱导miR-145并抑制其靶点,且该过程依赖p53激活。提示卡铂杀伤细胞的机制之一可能是通过DNA损伤激活p53进而诱导miR-145并失调其靶点。
要点
- 卡铂剂量依赖性诱导头颈鳞癌细胞miR-145表达
- 卡铂抑制miR-145直接靶点的表达
- p53抑制剂可逆转卡铂对miR-145及其靶点的作用
核心结论
- 卡铂杀伤头颈鳞癌细胞的一种可能机制是通过其DNA损伤特性激活p53,进而诱导miR-145并同时失调其直接靶点。
研究设计与样本
- 实验室研究,使用头颈鳞状细胞癌细胞,采用Cell Viability Detection Kit-8评估增殖能力,qRT-PCR检测miR-145及靶点表达,Western blot检测p53及其乙酰化水平。
主要发现
- 卡铂以剂量依赖方式诱导miR-145表达并抑制miR-145直接靶点的表达。
- 在卡铂处理的细胞中,用pifithrin-α抑制p53可降低miR-145表达并逆转对miR-145直接靶点的抑制。
临床怎么用
- 为理解卡铂在头颈鳞癌中的分子作用提供了p53/miR-145轴的新视角,但尚未提供临床用药指导。
局限性
- 研究为实验室层面,未报告样本量、统计显著性数值及临床验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In this study, we aimed at investigating the expressions of miR-145 and its well-characterized direct targets on carboplatin treatment. STUDY DESIGN: Laboratory study. METHODS: The effect of carboplatin and miR-145 on the proliferative capacity of head and neck squamous cell carcinoma cells was evaluated using Cell Viability Detection Kit-8. Expressions of miR-145 and its targets were evaluated using quantitative real-time polymerase chain reaction on carboplatin treatment and p53 inhibition. Western blot was used to measure the levels of p53 and its acetylated versions in cells treated with carboplatin and/or pifithrin-α. RESULTS: We demonstrated that carboplatin induced the expression of miR-145 in a dose-dependent manner and suppressed the expressions of miR-145 direct targets. In addition, we showed that inhibition of p53 by pifithrin-α in carboplatin-treated cells reduced miR-145 expression and reversed the suppression of miR-145 direct targets. CONCLUSIONS: Considering all these findings together, one of the proposed mechanisms of carboplatin to kill cells might be the induction of miR-145 and deregulation of its targets in parallel, via p53 activation, which happens through carboplatin's DNA-damaging property. To the best of our knowledge, these findings are the first to reveal the relationship between carboplatin and miR-145 in cancer cells. LEVEL OF EVIDENCE: NA Laryngoscope, 2019.
引用
- Kilic A, Barlak N, Sanli F, et al. Mode of action of carboplatin via activating p53/miR-145 axis in head and neck cancers. Laryngoscope. 2019. PMID: 31886905. doi:10.1002/lary.28492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。